|Tested species reactivity||Horse, Human|
|Published species reactivity||Human, Not Applicable|
|Host / Isotype||Mouse / IgG2b, kappa|
|Immunogen||A431 human epidermoid cells|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
|Immunoprecipitation (IP)||2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-13048 targets Epidermal Growth Factor Receptor in FACS, IF, IHC (F), and IP applications and shows reactivity with Equine and Human samples.
The MA5-13048 immunogen is a431 human epidermoid cells.
The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor. Binding of the protein to a ligand induces receptor dimerization and tyrosine autophosphorylation and leads to cell proliferation. Mutations in this gene are associated with lung cancer. Multiple alternatively spliced transcript variants that encode different protein isoforms have been found for this gene.
IP-MS enrichment of EGFR (LFQ intensity): EGFR was enriched 47-fold from A549 lysate compared to background proteins, using the optimized IP-MS workflow with Pierce MS-Compatible Magnetic IP Kit protein A/G (Part No. 90409) and EGFR antibody (Part No. MA5-13048). The STRING database (www.string-db.org) was used to identify the protein interactor list. See more information on IP-MS verification of antibody selectivity. IP-MS validation info.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
Deep and high-resolution three-dimensional tracking of single particles using nonlinear and multiplexed illumination.
MA5-13048 was used in immunocytochemistry to use nonlinear and multiplexed illumination to get high-resolution and deep three-dimensional tracking of single particles
|Perillo EP,Liu YL,Huynh K,Liu C,Chou CK,Hung MC,Yeh HC,Dunn AK||Nature communications (6:null)||2015|
|Not Applicable||Not Cited||
High levels of reactive oxygen species in gold nanoparticle-targeted cancer cells following femtosecond pulse irradiation.
MA5-13048 was used in immunocytochemistry to use gold nanoparticles and ultrashort pulses to kill cancer cells
|Minai L,Yeheskely-Hayon D,Yelin D||Scientific reports (3:null)||2013|
The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2.
MA5-13048 was used in immunocytochemistry to investigate the effect of the constitutive activity of EGFRvIII on wild-type EGFR and erbB2 in OVCA 433 cells
|Zeineldin R,Ning Y,Hudson LG||The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (58:529)||2010|
Effects of cisplatin, alpha-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-1 (ICAM-1), and epidermal growth factor receptor (EGFR) in oral cancer cell lines.
MA5-13048 was used in immunocytochemistry to investigate the effects of chemotherapeutic agents cisplatin, alpha-interferon, and 12-cis retinoic acid on the expression of mutliple proteins in oral cancer cell lines
|Sundelin K,Roberg K,Grénman R,Håkansson L||Journal of oral pathology and medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (36:177)||2007|
Both clathrin-positive and -negative coats are involved in endosomal sorting of the EGF receptor.
MA5-13048 was used in immunocytochemistry to study the endosomal sorting of EGFR and the role played by clathrin-positive and clathrin-negative coats
|Myromslien FD,Grøvdal LM,Raiborg C,Stenmark H,Madshus IH,Stang E||Experimental cell research (312:3036)||2006|
Activation of the epidermal growth factor (EGF) receptor induces formation of EGF receptor- and Grb2-containing clathrin-coated pits.
MA5-13048 was used in immunocytochemistry to study clathrin-coated pits containing EGF, EGFR and Grb2 and the role of EGFR activation in their formation
|Johannessen LE,Pedersen NM,Pedersen KW,Madshus IH,Stang E||Molecular and cellular biology (26:389)||2006|
The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane.
MA5-13048 was used in immunocytochemistry to study the inhibitory effect of ErbB2 on EGF-induced formation of clathrin-coated pits
|Haslekås C,Breen K,Pedersen KW,Johannessen LE,Stang E,Madshus IH||Molecular biology of the cell (16:5832)||2005|
Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines.
MA5-13048 was used in immunocytochemistry to investigate the patterns of colony formation in cell lines derived from carcinomas
|Locke M,Heywood M,Fawell S,Mackenzie IC||Cancer research (65:8944)||2005|
Herceptin-induced inhibition of ErbB2 signaling involves reduced phosphorylation of Akt but not endocytic down-regulation of ErbB2.
MA5-13048 was used in immunocytochemistry to study the role of Akt phosphorylation in the inhibition of ErbB2 signaling by Herceptin
|Longva KE,Pedersen NM,Haslekås C,Stang E,Madshus IH||International journal of cancer (116:359)||2005|
Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma.
MA5-13048 was used in immunohistochemistry to describe histological features of a tumor from a patient with pleuropulmonary blastoma
|Yu L,Cheng H,Yang SJ||Fetal and pediatric pathology (33:1)||2014|
Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy.
MA5-13048 was used in immunohistochemistry to investigate the sub-classification invasive breast carcinoma patients and its prognostic significance
|Goldstein NS,Decker D,Severson D,Schell S,Vicini F,Margolis J,Dekhne NS||Cancer (110:1687)||2007|
Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
MA5-13048 was used in immunohistochemistry to study beta-catenin expression in oral cancer
|Odajima T,Sasaki Y,Tanaka N,Kato-Mori Y,Asanuma H,Ikeda T,Satoh M,Hiratsuka H,Tokino T,Sawada N||Human pathology (36:234)||2005|
Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.
MA5-13048 was used in immunohistochemistry to study the prognostic value of nuclear-localized EGFR in beast cancer
|Lo HW,Xia W,Wei Y,Ali-Seyed M,Huang SF,Hung MC||Cancer research (65:338)||2005|
Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer.
MA5-13048 was used in immunohistochemistry to study the expression of HER1-4 in 220 cases of breast carcinoma and the correlation with survival
|Witton CJ,Reeves JR,Going JJ,Cooke TG,Bartlett JM||The Journal of pathology (200:290)||2003|
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis.
MA5-13048 was used in immunohistochemistry to investigate the incidence of EGFRvIII in human invasive breast cancer
|Ge H,Gong X,Tang CK||International journal of cancer (98:357)||2002|
Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer.
MA5-13048 was used in immunoprecipitation to study tumor penetration and EGFR saturation by panitumumab and the correlation with therapeutic efficacy in a xenograft model of human epidermoid carcinoma
|Freeman DJ,McDorman K,Ogbagabriel S,Kozlosky C,Yang BB,Doshi S,Perez-Ruxio JJ,Fanslow W,Starnes C,Radinsky R||Molecular cancer (11:null)||2012|
Optical nanomanipulations of malignant cells: controlled cell damage and fusion.
MA5-13048 was used in blocking or activating experiment to study optical nanomanipulations of malignant cells
|Minai L,Yeheskely-Hayon D,Golan L,Bisker G,Dann EJ,Yelin D||Small (Weinheim an der Bergstrasse, Germany) (8:1732)||2012|
Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
MA5-13048 was used in blocking or activating experiment to study ligand-independent dimer formation of epidermal growth factor receptor
|Yu X,Sharma KD,Takahashi T,Iwamoto R,Mekada E||Molecular biology of the cell (13:2547)||2002|
Ultrastructural characterization of giant endosomes induced by GTPase-deficient Rab5.
MA5-13048 was used in flow cytometry to study the ultrastructure of giant endosomes induced by GTPase-deficient Rab5
|Wegner CS,Wegener CS,Malerød L,Pedersen NM,Progida C,Prodiga C,Bakke O,Stenmark H,Brech A||Histochemistry and cell biology (133:41)||2010|
The juxtamembrane region of the EGF receptor functions as an activation domain.
MA5-13048 was used in flow cytometry to study the role of the juxtamembrane region of the EGF receptor as an activation domain
|Red Brewer M,Choi SH,Alvarado D,Moravcevic K,Pozzi A,Lemmon MA,Carpenter G||Molecular cell (34:641)||2009|
Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
MA5-13048 was used in flow cytometry to study the interplay among epidermal growth factor receptor, ErbB2, and ErbB3 during the treatment of breast cancer and its therapeutic significance
|Pedersen NM,Breen K,Rødland MS,Haslekås C,Stang E,Madshus IH||Molecular cancer research : MCR (7:275)||2009|
Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.
MA5-13048 was used in flow cytometry to study the regulation of EGF receptor signaling by plasma membrane erbB2
|Offterdinger M,Bastiaens PI||Traffic (Copenhagen, Denmark) (9:147)||2008|